Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 04/02/2020.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-412-02
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)
- Initial Posting
- 04/02/2020
- Revised Date